The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Aratana Therapeutics Inc. Common 03874P101 33,923 2,118,845 SH   SOLE   2,118,845 0 0
Celladon Corporation Common 15117E107 15,162 800,542 SH   SOLE   800,542 0 0
Conatus Pharmaceuticals, Inc. Common 20600T108 8,488 1,192,080 SH   SOLE   1,192,080 0 0
EnteroMedics, Inc. Common 29365M208 1,024 1,113,168 SH   SOLE   1,113,168 0 0
EpiZyme, Inc. Common 29428V104 40,637 2,163,819 SH   SOLE   2,163,819 0 0
MacroGenics, Inc. Common 556099109 99 3,168 SH   SOLE   3,168 0 0
Mast Therapeutics, Inc. Common 576314108 1,250 2,551,851 SH   SOLE   2,551,851 0 0
Nevro Corporation Common 64157F103 32,914 686,704 SH   SOLE   686,704 0 0
PharmAthene, Inc. Common 71714G102 10,347 6,347,614 SH   SOLE   6,347,614 0 0
Portola Pharmaceuticals, Inc. Common 737010108 46,337 1,220,672 SH   SOLE   1,220,672 0 0
Proteon Therapeutics, Inc. Common 74371L109 11,437 983,381 SH   SOLE   983,381 0 0
Radius Health, Inc. Common 750469207 240,014 5,831,253 SH   SOLE   5,831,253 0 0
Sangamo Biosciences, Inc. Common 800677106 353 22,487 SH   SOLE   22,487 0 0
Trivascular Technologies, Inc. Common 89685A102 18,637 1,776,692 SH   SOLE   1,776,692 0 0
Verastem, Inc. Common 92337C104 8,306 816,683 SH   SOLE   816,683 0 0